Hearing On Neurontin Injunction Closes Without Ruling

Law360, New York (October 7, 2004, 12:00 AM EDT) -- A hearing on Pfizer’s motion for a preliminary injunction against a generic version of epilepsy drug Neurontin was adjourned Thursday with no decision.

Attorneys for Pfizer had hoped to persuade Judge John C. Lifland of the U.S. District Court for the District of New Jersey to bar generics maker Alpharma from launching a generic version of the $3 billion drug.

Analysts who have been observing the case aren’t optimistic about Pfizer’s chances.

"Based on the six hours of arguments we listened to yesterday, we are unswayed...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.